ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,830 | -15.7% | 351,064 | 0.0% | 0.08% | -4.5% |
| Q2 2023 | $324,734 | -15.1% | 351,064 | 0.0% | 0.09% | -22.6% |
| Q1 2023 | $382,660 | -25.3% | 351,064 | 0.0% | 0.12% | -20.1% |
| Q4 2022 | $512,553 | +36.0% | 351,064 | 0.0% | 0.14% | +42.6% |
| Q3 2022 | $377,000 | -36.9% | 351,064 | 0.0% | 0.10% | -38.0% |
| Q2 2022 | $597,000 | -17.4% | 351,064 | 0.0% | 0.16% | -13.3% |
| Q1 2022 | $723,000 | +41.5% | 351,064 | +157.6% | 0.19% | +46.9% |
| Q4 2021 | $511,000 | +151.7% | 136,266 | +446.0% | 0.13% | -20.5% |
| Q2 2016 | $203,000 | -71.6% | 24,955 | -71.7% | 0.16% | -73.9% |
| Q1 2016 | $716,000 | +23.4% | 88,100 | +83.2% | 0.62% | +19.5% |
| Q4 2015 | $580,000 | – | 48,100 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |